Eye Patch Therapy for Central Serous Retinopathy (CSR)
Phase 1
Completed
- Conditions
- Central Serous Retinopathy (CSR)
- Interventions
- Device: Eye Patching
- Registration Number
- NCT02036632
- Lead Sponsor
- Washington University School of Medicine
- Brief Summary
First, this study will investigate the viability of 24-hour eye patching as a potential treatment modality for CSR. Second, this study will assess a potential physiologic explanation for CSR, namely if inhibition of photic stimulation of the diseased retina will aid in ameliorating disease severity and disease duration.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
- Adults 18 years of age and older
- Both males and females
- Patients diagnosed with active central serous retinopathy
- Patients who are willing to use an eye patch in the affected eye for 24 hours
- Patients who are able to make the follow up appointments as required by the study
Read More
Exclusion Criteria
- Individuals under 18 years of age
- Patients with vision less than 20/40 in the unaffected eye.
- Patients who are not able to undergo mfERG testing in a realiable manner.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Eye Patching Eye Patching Intervention
- Primary Outcome Measures
Name Time Method Change in multi-focal ERG response 24 hours Change in multi-focal ERG response and macular thickness after 24-hour patch therapy in patients with CSR 24 hours This study is a prospective control trial that will compare 24-hour eye patch therapy with the current standard of care in patients with central serous retinopathy (CSR).
- Secondary Outcome Measures
Name Time Method macular thickness 24 hours
Trial Locations
- Locations (1)
Washington Universtiy School of Medicine
🇺🇸St Louis, Missouri, United States